Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Alclinical Research, S.L. | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an epidemiological, observational, prospective, multicentric study in 400 adult patients admitted to hospital for mild acute pancreatitis to to assess the prognostic value of the antithrombin III in the development of moderate or severe acute pancreatitis.
This is an epidemiological, observational, prospective, multicentric study in 400 adult patients admitted to hospital for mild acute pancreatitis to to assess the prognostic value of the antithrombin III in the development of moderate or severe acute pancreatitis.
In the context of clinical practice of general surgery and apparatus digestive services, patients entering with mild acute pancreatitis will be asked to participate in the study and if so, they will sign the informed consent.
On admission, demographic and anthropometric data of the patient will be recorded, as well as medical history, patient's admission data and vital signs. Patient's blood will be drawn for analysys and the risk of organ failure will be measured by modified Marshall and Apache II scales. The assessments and procedures performed are the standard practice at the center.
At 24 hours (± 3 hours) and at 7 days (or nine days to avoid weekends) after admisison, vital signs will be recorded, laboratory tests will be performed and the risk of organ failure will be measured by modified Marshall and Apache II scales.
At discharge of the patient (regardless of when it occurs), the outcome of the acute pancreatitis will be recorded.
. Those patients discharged within the first month after admission will be visited or called (according to standard practice at the center) one month after arrival, to record follow-up data, including health condition, readmissions and abdominal pain evaluation by visual analog scale.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| antithrombin III levels vs maximum seriousness grade of acute pancreatitis | Levels of antithrombin III at admission and at 24h will be related with maximum seriousness grade of acute pancreatitis reached during patient's admission at site by logistic regression models | At Admission and at 24h |
| Measure | Description | Time Frame |
|---|---|---|
| result of modified Marshall and Apache II scales | Admission and at 24h | |
| antithrombin III levels vs mortality | Levels of antithrombin III at admission and at 24h will be related with mortality rates by logistic regression models |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult patients with mild acute pancreatitis
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Francisco Javier García Borobia, Dr. | Contact | +34 93 7231010 | 21461 | fjgarcia@tauli.cat |
| Name | Affiliation | Role |
|---|---|---|
| Francisco Javier García Borobia, Dr. | Corporacion Parc Tauli | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Corporació Sanitària Parc Taulí | Recruiting | Sabadell | Barcelona | 08208 | Spain |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37801622 | Derived | Garcia Borobia F, Flores Clotet R, Bejarano Gonzalez N, Gonzalez Martinez S, Garcia Monforte N, Romaguera Monzonis A, Gonzalez Abos C, Gonzalez Abos S, Lucas Guerrero V, Perez Perarnau A, Mota Villaplana F. Predictive Value of Antithrombin III and d -Dimer in the Development of Moderate-To-Severe Acute Pancreatitis : A Prospective, Observational Study (AT-PROPANC). Pancreas. 2023 Apr 1;52(4):e241-e248. doi: 10.1097/MPA.0000000000002245. Epub 2023 Sep 20. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010195 | Pancreatitis |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| From date of admission until the end of study or date of death from any cause, whichever came first, assessed up to 1 month" |
| antithrombin III levels vs organic failure | Levels of antithrombin III at admission and at 24h will be related with organic failure rates by logistic regression models | From date of admission until the end of study or date of organic failure, whichever came first, assessed up to 1 month" |
| antithrombin III levels vs necrosis and infection rates | Levels of antithrombin III at admission and at 24h will be related with necrosis and infection rates by logistic regression models | From date of admission until the end of study or date of necrosis or infection diagnosis, whichever came first, assessed up to 1 month" |
| Hospital de Sant Joan Despí Moisés Broggi | Recruiting | Sant Joan Despí | Barcelona | 08970 | Spain |
|